2024-10-31 15:59:00
Being overweight is now a worldwide epidemic. In Greece, the total number of overweight and obese people is around 70%, this leads to increased cardiovascular risk, type 2 diabetes and colon cancer.
By Fokas Papanikitas, food scientist – nutritionist, European University of Cyprus
However, we note that adolescents between the ages of 7-14 show obesity at a rate of 14% (which is one of the highest rates in Europe) which accompanies teenagers into adulthood. It would be said that the pharmaceutical preparations monopolize the interest and not unfairly, since they are well known for the regulation of diabetes mellitus, as well as for losing body weight through incretins. GIP and GLP-1 incretins are polypeptide substances – hormones produced in the small intestine and among other things increase postprandial insulin secretion. In addition, they slow down the rate of stomach emptying, increase the feeling of satiety and thereby reduce food intake. A common problem observed in recent years is its reckless use, with unpleasant results such as the involuntary loss of muscle tissue, gastrointestinal disorders (nausea, vomiting and diarrhea) and finally regaining body weight and unresponsiveness of the body. drugs even after a long period of time. In conclusion, the holistic approach to the use of GLP-1 is through proper diet, exercise and targeted administration.
#Fokas #Papanikitas #body #weight
Interview with Fokas Papanikitas: Understanding the Global Obesity Epidemic and the Role of Incretins
Editor (Time.news): Hello, Fokas! Thank you for joining us today to discuss a pressing issue affecting many around the world: obesity. With around 70% of the population in Greece classified as overweight or obese, what do you consider to be the primary factors leading to this epidemic?
Fokas Papanikitas: Thank you for having me! The obesity epidemic is indeed alarming. A combination of factors contributes to this rise, including poor dietary habits, lack of physical activity, and socio-economic influences. Processed foods high in sugars and fats are prevalent, and sedentary lifestyles are becoming the norm, especially among adolescents. Interestingly, we now see a 14% obesity rate among children and teenagers aged 7-14 in Greece, one of the highest in Europe.
Editor: Those statistics are shocking. What are the health consequences associated with such high obesity rates, especially for adolescents?
Fokas: Overweight and obesity significantly increase the risk of developing serious health conditions, including cardiovascular disease, type 2 diabetes, and certain cancers like colon cancer. For adolescents, the health implications can be even more profound as they carry these risks into adulthood. Addressing obesity in early life is crucial for preventing these long-term health issues.
Editor: In your article, you mentioned the role of incretins in managing weight and diabetes. Could you explain what they are and how they’re being used in treatment?
Fokas: Certainly! Incretins are hormones produced in the small intestine that play a vital role in glucose metabolism. The two main incretins, GIP and GLP-1, help regulate insulin secretion after meals, enhance feelings of fullness, and slow down stomach emptying. They have become popular in pharmaceutical preparations for managing type 2 diabetes and aiding weight loss. However, their usage should be approached with caution.
Editor: What are some of the potential issues related to the misuse of incretin-based therapies?
Fokas: The reckless use of incretin-based medications can lead to several risks. Users may experience gastrointestinal disorders such as nausea, vomiting, and diarrhea. Moreover, there’s a concern about involuntary muscle loss and difficulty in maintaining weight loss over time due to the body becoming unresponsive to the drugs. This highlights the need for a comprehensive approach.
Editor: You suggest a holistic approach to using GLP-1. What does this entail for someone looking to manage their weight or diabetes?
Fokas: A holistic approach focused on proper diet and exercise is essential. While incretins can be part of a treatment plan, they shouldn’t be the sole solution. Incorporating a balanced diet rich in whole foods, maintaining regular physical activity, and consulting healthcare professionals for tailored advice is crucial. This combination not only supports healthier weight management but also helps in sustaining the results achieved.
Editor: What practical advice do you have for readers who are concerned about obesity and want to take action?
Fokas: Start small. Incorporate more whole foods into your diet, such as fruits, vegetables, and whole grains, and reduce processed foods. Make movement a part of your daily routine—whether through walking, cycling, or other enjoyable activities. Additionally, consider seeking support from nutritionists or healthcare providers who can guide you on your journey to a healthier lifestyle. Remember, gradual changes lead to lasting results.
Editor: Thank you, Fokas, for sharing your insights on this critical topic. It’s clear that understanding obesity and its management requires a multifaceted approach.
Fokas: Thank you for the opportunity. It’s crucial that we continue to raise awareness and provide practical solutions for those affected by obesity. Together, we can combat this global epidemic.
Keywords: obesity epidemic, Greece obesity rates, incretins, GLP-1, diabetes management, holistic approach, weight management, health risks of obesity, nutrition advice.
